| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/29/2004 | CN1533391A Tricyclic compounds and their uses |
| 09/29/2004 | CN1533390A Drugs containing triazaspiro [5,5] undecane derivatives as the active ingredient |
| 09/29/2004 | CN1533388A Substituted piperazine compounds and their use as fatty acid oxidation inhibitors |
| 09/29/2004 | CN1533387A 1-phenysulfonyl-1,3-dihydro-2H-indole-2-one derivatives, their preparation and their therapeutic use |
| 09/29/2004 | CN1533382A 哌嗪衍生物 Piperazine derivatives |
| 09/29/2004 | CN1533374A Substitutled cyclohexane-1,4-diamine derivatives |
| 09/29/2004 | CN1533372A Process and intermediates to prepare latanoprost |
| 09/29/2004 | CN1533293A Combinations comprising epothilones and pharmaceutical uses thereof |
| 09/29/2004 | CN1533292A Medicament inhititing sodium/calcium exchange system |
| 09/29/2004 | CN1533284A Use of biologically active HIV-1 Tat, fragments or derivatives thereof for preventing or therapeutic vaccination and/or treating other diseases |
| 09/29/2004 | CN1533283A Use of osteopontin for treatment and/or prevention of neurologic diseases |
| 09/29/2004 | CN1533281A Use of ginkeo bilobwa extracts for preparing medicine for treating sarcopenia |
| 09/29/2004 | CN1533280A Carbohydrate modifying agent and drinks containing the same |
| 09/29/2004 | CN1533279A Organo-phosphorous compounds for activating gamma/delta T-cells |
| 09/29/2004 | CN1533278A Naphtothiazine positive allosteric AMPA receptor modulators (PAARM) |
| 09/29/2004 | CN1533277A Preventives or remedies for diseases caused by e NOS expression |
| 09/29/2004 | CN1533276A Use of thiazole derivatives for preparing medicine for protecting mitochondria |
| 09/29/2004 | CN1533275A Use of 4-[(4-thiazolyl) phenoxl] alkoxy-benzamidine derivatives for treatment of osteoporosis |
| 09/29/2004 | CN1533274A Benzofuranes and their use in treatment of artrial fibrillation |
| 09/29/2004 | CN1533273A Metronomic dosing of taxanes |
| 09/29/2004 | CN1533272A Zinc containing compositions for anti-viral use |
| 09/29/2004 | CN1533271A 5-amino levulic acid as photosensitizer in ligh chemical therapy and cpmbination of its ester and another photosensitizer, and their use in therapy |
| 09/29/2004 | CN1533270A Oral administered dosage form of GABA anolog prodrugs having reduced toxicity |
| 09/29/2004 | CN1533269A Carotenoids as anti-hypertension agents |
| 09/29/2004 | CN1533268A Pharmaceutical composition which comprise solid dispersion of hydroxypropylethyl cellulose phthalate polymer |
| 09/29/2004 | CN1532535A Method for detecting compound having manoamine oxidase inhibiting activity |
| 09/29/2004 | CN1532202A ANtisense oligonucleotides of targeting human cell death inhibiting protein family member survival protein mRNA, medicinal composition containing them and its use for treating cancer |
| 09/29/2004 | CN1532198A Quaternary chelidonine derivatives |
| 09/29/2004 | CN1532196A Quinic compound containing quaternary ammonium group and its preparation and medicina use |
| 09/29/2004 | CN1532182A Preparation of piper laetispicum effective part and its use in medical therapy and health field |
| 09/29/2004 | CN1531967A Use of mometasone furoate for treating airway nassage and lung diseases |
| 09/29/2004 | CN1531952A 强身胶囊 Physical Capsules |
| 09/29/2004 | CN1531932A Prepn process and formula of compound chondroitin sulfate tablet |
| 09/29/2004 | CN1531931A Method for improving solubility of clarithromycin |
| 09/29/2004 | CN1531930A Medicinal composition for curing cerebrovascular disease |
| 09/29/2004 | CN1531929A Brevis capine drip. pill and its preparing process |
| 09/29/2004 | CN1531928A Panaxitriol saponin preparation with biological activity and use |
| 09/29/2004 | CN1531927A Panaxadiol saponin preparation with biological activity and use |
| 09/29/2004 | CN1531926A Reinforced type lecithin capsule |
| 09/29/2004 | CN1531925A Process for preparing colatemo solid preparation and its solid preparation |
| 09/29/2004 | CN1531924A Use of isovaleric acid derivatives CNS inhibitors in preparing medicine for curing headache |
| 09/29/2004 | CN1531923A Use of all-trans vitamin A acid in preparing medicine for curing hypertension myocardial hypertrophy |
| 09/29/2004 | CN1531922A Limonene soft capsule oral medicine for treating biliary tract disease and its preparing process |
| 09/29/2004 | CN1168738C Biotin derivatives |
| 09/29/2004 | CN1168736C Composition and method for delivery of nucleic acids |
| 09/29/2004 | CN1168735C New lipid esters of nucleoside monophosphates and their use as immunosuppressive drugs |
| 09/29/2004 | CN1168734C Novel erythromycin derivatives, method for preparing same, and use thereof as drug |
| 09/29/2004 | CN1168733C Novel prodrugs for therapy of tumors and inflammatory disorders |
| 09/29/2004 | CN1168728C Pyrrolo-isoquinoline and tetrahydropyrrolko-isoquinoline derivatives and their use as mediators of 5-HT7 reactor |
| 09/29/2004 | CN1168727C Substituted benzimidazole |
| 09/29/2004 | CN1168726C Novel vitamin D analogues |
| 09/29/2004 | CN1168725C Formulation for protection against oxidative stress containing beozofuranone derivatives |
| 09/29/2004 | CN1168721C 5-cyano-2-aminopyrimidine derivatives |
| 09/29/2004 | CN1168720C Aryl alkanoylpyridazines compounds |
| 09/29/2004 | CN1168719C 6-phenylpyridyl-2-amine derivatives and pharmaceutical composition and use |
| 09/29/2004 | CN1168717C Novel intermediates for prepn. of antihisatminic piperidine derivatives |
| 09/29/2004 | CN1168715C Novel benzene amine compound, its prepn. process and medicinal compsns. contg. them |
| 09/29/2004 | CN1168714C Arylpiperazine derivatives useful as uroselective alpha-adrenoceptor blockers |
| 09/29/2004 | CN1168712C Crystaline forms of sodium salt of 5-chloro-2-methoxy-N-(2(4- methoxy-3-methylaminothio carbonylamino sulfonylphenyl)ethyl) benzamide |
| 09/29/2004 | CN1168711C Reversible aqueous pH sensitive lipidizing reagents, compositions and methods of use |
| 09/29/2004 | CN1168709C Alpha-hydroxy, amino and fluoro derivatives of beta-sulphenyl hdyroxamic acids matrix metalloproteinase inhibitors |
| 09/29/2004 | CN1168707C 4-guanidinobenzamides antifertility compounds |
| 09/29/2004 | CN1168702C Acyl dipeoptides, prepn method and pharmaceutical compsns. contg. same |
| 09/29/2004 | CN1168693C Substituted phenols and thiophenols useful as antioxidant agents |
| 09/29/2004 | CN1168501C Poly saccharide-protein combination vaccine |
| 09/29/2004 | CN1168499C Medicament for optimising mucosal viscosity and stimulating intestinal function |
| 09/29/2004 | CN1168480C Externally applied ointment for treating burns and its prepn |
| 09/29/2004 | CN1168468C Cream for treating allergic dermatitis, eczama and other skin inflammations |
| 09/29/2004 | CN1168453C Application of N-acetyl-D-aminoglucose in preparing medicine to prevent anjd treat motion sickness |
| 09/29/2004 | CN1168452C Use of methoxymorpholino dexorubicin for treatment of liver tumor |
| 09/29/2004 | CN1168451C Use of thiazolidinedione and sulphonylurea composition in preparing medicine for treating diabetes |
| 09/29/2004 | CN1168450C Novel formulation |
| 09/29/2004 | CN1168449C Medicine against human papilloma virus |
| 09/29/2004 | CN1168448C Medicament for preventing and/or treating a memmary carcinoma, containing a steroidal aromatase inhibitor |
| 09/29/2004 | CN1168447C Use of oxazolidinones for preparation of medicament for transdermal delivery |
| 09/29/2004 | CN1168446C Application of arecaline hydrobromide as medicine for arrhythmia |
| 09/29/2004 | CN1168445C Concentrated clear solution contg. biocefalin as brain metabolism improving medicine for intravenous injection after diluting it |
| 09/29/2004 | CN1168444C Nifedipine drop pill preparation and its making method |
| 09/29/2004 | CN1168443C Methods and compsns. for stimulating neurite growth using compounds with affinity for FKBP12 in combination with neurotrophic factors |
| 09/29/2004 | CN1168442C Methods and compsns. for stimulating neurite growth |
| 09/29/2004 | CN1168441C Use of dexmedetomidine for ICU sedation |
| 09/29/2004 | CN1168440C Levodopa/carbidopa/entacapone pharmaceutical preparation |
| 09/29/2004 | CN1168439C Drug delivery device, especially for delivery of progestins and estrogens |
| 09/29/2004 | CN1168436C Antiplaque oral composition and its use |
| 09/28/2004 | USRE38604 And d-betahydroxybutyrate, or acetoacetate anions; electrolyte solutions for electrolyte and fluid therapy, parenteral nutrition and dialysis |
| 09/28/2004 | US6797826 Acylating a starting compound containing carboxy or amide or ester-isopropylbenzene compound with an chlorobutanoylhalide to form mixture of regioisomer, hydrolyzing to form second mixture and recovering substantially pure rgioismor |
| 09/28/2004 | US6797806 Multimeric proteins;for diagnosis and therapy of disorders involving complement activity (globulins) and various inflammatory and immune disorders |
| 09/28/2004 | US6797732 Oral solid for treating parkinson's disease where a subtantial portion of carbidopa is separate from entacapone and levodopa |
| 09/28/2004 | US6797731 Resorcinol derivatives |
| 09/28/2004 | US6797730 Peptide deformylase inhibitors |
| 09/28/2004 | US6797729 Therapeutic glutamine and N-actyl-cysteine composition |
| 09/28/2004 | US6797728 Use of intracellular calcium chelators to increase surfactant secretion in the lungs |
| 09/28/2004 | US6797727 Such as restenosis and atherosclerosis. |
| 09/28/2004 | US6797724 To eliminate boophilus microplus in cattle and lice and blowfly in sheep |
| 09/28/2004 | US6797722 Use of 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole for the treatment of autoimmune diseases |
| 09/28/2004 | US6797721 Contacting the cancer cell with a phorboxazole derivative to inhibit growth of cancer cells, induction of apoptosis and inhibition of metastises |
| 09/28/2004 | US6797719 Osteoporosis; antilipemic agents; anticancer agents |
| 09/28/2004 | US6797718 Ether substituted imidazopyridines |
| 09/28/2004 | US6797716 Imidazonaphthyridines |
| 09/28/2004 | US6797714 Hypoglycemic agents; antidiabetic agents; side effect reduction |